MANE Veradermics Inc.
Health Care, filed as VERADERMICS INC (COMMON STOCK), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
Bought by 2 managers in 2026 Q2, sold by 1
- 3 Owners
- Max 0.9%
- $317M
- 1 new 1 add 1 reduce
In 2026 Q2 Lee Ainslie opened a position in Veradermics, Ron Baron added, and Andreas Halvorsen trimmed.
Who owns this now
Largest portfolio weights among holders, up to 0.9% (Lee Ainslie, Maverick Capital). Not free-float ownership.
Who owns MANE
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| Andreas Halvorsen, Viking Global Investors | Reduce −7.6% | 1,561,494 | $192M | History | |
| Lee Ainslie, Maverick Capital | New 0.86% | 789,980 | $97M | History | |
| Ron Baron, Bamco Inc. (Baron Capital) | Add +284.8% | 229,581 | $28M | History |
Insider trades
Open-market buys and sales by MANE's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $54.1M bought by 5 insiders
- $91.1M sold by 2 insiders outside a trading plan
- $12M sold by 2 insiders under 10b5-1 plans
-
Montanova Capital, LLC Director, +3 joint filersSale$80.4M 750,000 shares at $107.25 62% of stakeTraded Aug 19 Filed Aug 21
-
Timothy August Durso Chief Technical OfficerPlanned sale$4.7M 43,500 shares at $107.82 36% of stakeTraded Aug 17 Filed Aug 18
-
Reid Alexander Waldman CEOPlanned sale$7.3M 67,500 shares at $107.86 28% of stakeTraded Aug 17 Filed Aug 18
-
John W Childs DirectorSale$10.7M 100,000 shares at $107.12 34% of stakeTraded Aug 12 Filed Aug 14
-
John W Childs DirectorBuy$5M 294,117 shares at $17.00 New stakeTraded Feb 5 Filed Feb 27
-
Suvretta Capital Management, LLC Director, +3 joint filersBuy$10.5M 282,674 shares at $37.30 +119% to stakeTraded Feb 4–6 Filed Feb 9
-
Vlad Coric DirectorBuy$2M 117,646 shares at $17.00 +58% to stakeTraded Feb 5 Filed Feb 5
-
Longitude Capital Partners V, LLC 10% owner, +3 joint filersBuy$18.3M 1,075,000 shares at $17.00 +110% to stakeTraded Feb 5 Filed Feb 5
Also filed in the last 12 months, not counted as buying or selling: 19 conversions, 4 option exercises, and 1 stock grant.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 424B3 | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| S-1 | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13D | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 1.01,3.02,9.01 | Filing Doc | |
| 424B4 | 424B3 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 2.02 | Filing Doc | |
| S-1 | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
| Metric | FY2025 |
|---|---|
| Net income | -$70M |
Balance sheet
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.